DnB Asset Management Portfolio holdings
AUM
$24.1B
1-Year Return
22.48%
This Quarter Return
+17.1%
1 Year Return
+22.48%
3 Year Return
+110.52%
5 Year Return
+180.23%
10 Year Return
+394.81%
AUM
$24.1B
AUM Growth
+$2.42B
(+11%)
Cap. Flow
-$698M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
41.39%
Holding
784
New
46
Increased
375
Reduced
264
Closed
68
Top Buys
| 1 |
Apple
AAPL
|
$260M |
| 2 |
Mastercard
MA
|
$204M |
| 3 |
TSMC
TSM
|
$168M |
| 4 |
Salesforce
CRM
|
$152M |
| 5 |
Atlassian
TEAM
|
$150M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$257M |
| 2 |
Amazon
AMZN
|
$231M |
| 3 |
Zscaler
ZS
|
$229M |
| 4 |
Take-Two Interactive
TTWO
|
$223M |
| 5 |
Microsoft
MSFT
|
$168M |
Sector Composition
| 1 | Technology | 41.1% |
| 2 | Financials | 13.21% |
| 3 | Communication Services | 12.66% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Healthcare | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZENA
701
ZenaTech, Inc. Common Stock
ZENA
$156M
| $183K | ﹤0.01% |
+49,329
| New | +$183K |
|
702
AGNC Investment
AGNC
$10.6B
| $169K | ﹤0.01% |
18,342
+2,010
| +12% | +$18.5K |
|
703
Regenxbio
RGNX
$476M
| $151K | ﹤0.01% |
18,396
-95
| -0.5% | -$780 |
|
704
Rithm Capital
RITM
$6.66B
| $134K | ﹤0.01% |
11,861
| – | – |
|
705
Intellia Therapeutics
NTLA
$1.25B
| $127K | ﹤0.01% |
+13,586
| New | +$127K |
|
706
AgEagle Aerial Systems
UAVS
$60.2M
| $125K | ﹤0.01% |
+119,082
| New | +$125K |
|
707
Viatris
VTRS
$12B
| $117K | ﹤0.01% |
13,154
-191,113
| -94% | -$1.71M |
|
708
Spectral AI
MDAI
$48.9M
| $107K | ﹤0.01% |
+43,024
| New | +$107K |
|
709
4D Molecular Therapeutics
FDMT
$309M
| $103K | ﹤0.01% |
27,754
-102
| -0.4% | -$378 |
|
|
VZLA
710
Vizsla Silver
VZLA
$1.25B
| $88.2K | ﹤0.01% |
30,000
| – | – |
|
711
Richtech Robotics
RR
$292M
| $77.8K | ﹤0.01% |
39,919
+12,204
| +44% | +$23.8K |
|
712
LanzaTech
LNZA
$43.8M
| $40.8K | ﹤0.01% |
1,487
-5,138
| -78% | -$141K |
|
713
Lucid Motors
LCID
$4.97B
| $32.4K | ﹤0.01% |
1,535
| – | – |
|
|
BORR
714
Borr Drilling
BORR
$862M
| $31.5K | ﹤0.01% |
17,227
| – | – |
|
715
Microvision
MVIS
$331M
| $27.8K | ﹤0.01% |
24,350
| – | – |
|
716
Atossa Therapeutics
ATOS
$99.6M
| $12.9K | ﹤0.01% |
15,600
| – | – |
|
717
Abacus Life
ABL
$625M
| – | – |
-10,556
| Closed | -$79.1K |
|
718
Aehr Test Systems
AEHR
$786M
| – | – |
-65,207
| Closed | -$475K |
|
719
Assurant
AIZ
$10.9B
| – | – |
-9,033
| Closed | -$1.89M |
|
720
Albemarle
ALB
$9.33B
| – | – |
-20,905
| Closed | -$1.51M |
|
721
Ally Financial
ALLY
$12.8B
| – | – |
-48,183
| Closed | -$1.76M |
|
722
Ambarella
AMBA
$3.44B
| – | – |
-6,259
| Closed | -$315K |
|
723
A.O. Smith
AOS
$10.2B
| – | – |
-30,602
| Closed | -$2M |
|
724
Aspen Aerogels
ASPN
$523M
| – | – |
-23,126
| Closed | -$148K |
|
725
Anavex Life Sciences
AVXL
$804M
| – | – |
-33,261
| Closed | -$285K |
|